MYL9 and neoplasm: An enrichment in rounded cells (Fig. 5f) and p-MLC2 levels (Fig. 5g and Supplementary 5i) was observed at the IF of shControl tumours compared with TBs, while loss of cell rounding and reduced Myosin II activity were measured in shFZD7 derived tumours (Fig. 5f, g).